您要查找的是不是:
- platelet survival time 血小板存活時(shí)間
- The aver age survival time was 6 months. 平均生存時(shí)間為6個(gè)月。
- It can prolong mouse s survival time in hypoxia. 醒神液能延長(cháng)小鼠耐缺氧存活時(shí)間。
- The median survival time for the entire sample was 34 months. 二年及五年的存活率各為65%25及25%25。
- The Prediction of the Survival Time about Hepatoma Patients with the BP Neural Network Method. BP神經(jīng)網(wǎng)絡(luò )預測肝癌患者生存期的研究。
- The overall response rate was 73.5% with a CR rate of 17.6% .Median survival time was 9.5 months. 治療總有效率為73.;5%25,其中完全緩解率為17
- The average survival time was prolonged but the rate of death protection was lower than that of Virazole group. 但死亡保護率低于病毒唑。
- Survival time and complete remission duration(CRD) were evaluated using Kaplan-Meier method. Kaplan -Meier方法評價(jià)兩組生存期和緩解期 ;
- In addition,the survival time was increased to 75%in CQ group and to 70% in DXM group. 此外,PLA2抑制劑可使家兔8h存活率由48%25提高到75%25(CQ組)和70%25(DXM組)。
- Asarinin could prolong the survival time of allografts,which was similar to CsA group(P>0.05). 移植心存活時(shí)間;CsA組、細辛脂素組和混合藥物組均較陽(yáng)性對照組顯著(zhù)延長(cháng)(P<0.;01)。
- DRC treatment prolonged the survival time of mice and the duration of electrocardiograph in trachea closed mice. 實(shí)驗結果表明:DRC能顯著(zhù)延長(cháng)小鼠常壓缺氧環(huán)境下的存活時(shí)間以及夾閉氣管小鼠心電圖消失時(shí)間;
- The survival time in BPI group was significantly higher than in physiological saline (PS) group. BPI治療組動(dòng)物存活時(shí)間明顯長(cháng)于生理鹽水組 ;
- PAP increased, survival time is shorttcr and MDA content increased after L-NNA infusion. 注入L-NNA后顯著(zhù)增加了休克后PAP,縮短了存活時(shí)間,并使血中MDA含量明顯增加。
- Tumor antigen specific CTLs may prevent metastasis in the LCI-D20 model and prolong the survival time. 腫瘤抗原特異性CTL可以預防LCI-D20模型肝癌發(fā)生轉移,延長(cháng)動(dòng)物存活時(shí)間。
- Median survival time(MST)was 10 months. Median time to progression (MTTP) was 8 months. 中位生存時(shí)間(MST)為10個(gè)月,中位進(jìn)展時(shí)間(MTTP)為8個(gè)月。
- The prognoses of these patients are extremely poor with a mean survival time of only 7.6 weeks. 這些病人的預后很差,平均存活時(shí)間只有7.;6周。
- The algorithm is applied to an example involving data for survival time for carcinoma of the oropharynx. 該算法應用于一個(gè)涉及口咽癌患者生存時(shí)間數據的例子。
- MSI-positive patients had significantly shorter survival time than MSI-negative ones had (P=0.0001). MSI陽(yáng)性患者的生存時(shí)間顯著(zhù)地低于MSI陰性患者(P=0.;0001)。
- Onders, noting that axonal sprouting will likely afford patients the longest survival time. 神經(jīng)軸分枝似乎可以提供與患者最長(cháng)的存活期。
- IHC analysis showed survival time were shorter in the high ki-67 group than in the low group(P<0.05). 臨床資料單因素分析顯示,臨床分期、結外侵犯情況、ECOG評分、血清乳酸脫氫酶水平及療效均為彌漫大B細胞淋巴瘤的獨立預后因素(P<0.;05),是否合并放療或使用美羅華對預后影響無(wú)統計學(xué)差別;